Tissue Source Site for Tumor Analysis

The Tissue Source Site for Tumor Analysis Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract is a specialized procurement vehicle for the National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC). The contract facilitates the acquisition of tissue samples, medical images, and related research materials from various medical centers and research institutions to support advanced cancer research. Primary services include tissue collection, processing, and digital imaging of biospecimens, with a focus on providing high-quality biological samples for proteomic tumor analysis and molecular oncology studies.

Task orders under this IDIQ consistently demonstrate a pattern of firm fixed-price delivery orders ranging from approximately $2,000 to $632,470, with typical contract durations between 6-24 months. Prime contractors frequently include academic medical centers and research institutions such as Cedars-Sinai Medical Center, Boston Medical Center, William Beaumont Hospital, Miedzynarodowy Instytut Onkologii Molekularnej, and Biopartners, Inc. The contract does not utilize set-aside designations and supports an international research network, with performance locations spanning the United States and Poland. All task orders are awarded by the National Cancer Institute, supporting the broader goal of comprehensive clinical proteomic data generation for cancer research through systematic tissue sample acquisition and analysis.